Mediflow Pharmaceutical products and prices in Pakistan
Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.
Follow price changes 🔒 Company report (Pharma Pro)Private pharmaceutical manufacturer - IV infusions · Karachi · Pakistan
Karachi pharmaceutical manufacturer specializing in large-volume intravenous infusion products using modern polypropylene bottle technology.
Mediflow Pharmaceutical products in Pakistan
Mediflow Pharmaceutical (Pvt) Ltd has 16 medicine presentations registered in Pakistan under 8 brands, covering 8 generic medicines. Most of its products are in Fluids & supportive care and Anti-infectives. Its brands with the most registered strengths and packs are Flow DS (Dextrose + Sodium chloride), Flow NS (Sodium chloride), Flow Dex (Water for Injection, Dextrose Anhydrous) and Flow Dex 10% (Dextrose Anhydrous, Dextrose). 16 products have an official DRAP price on MedInfoBase. See all 8 brands A to Z
What is sourced, and how recent is it?
Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.
Company profile
- Legal / official name
- Mediflow Pharmaceutical (Pvt.) Limited
- Company type
- Private pharmaceutical manufacturer - IV infusions
- Address
- Plot No. ID-100, Sector 30, Korangi Industrial Area, Karachi, Pakistan
- Website
- mediflowpharma.com ↗
- Phone
- +92 21 35073176; +92 21 35073171
- Official contact
- Contact page ↗
- Corporate source details checked
- 16 Aug 2026
- Corporate profile completeness
- 100%
Company location
A sourced company location is recorded. Use the map link below for directions.
Portfolio at a glance
RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.
PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.
IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.
Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.
Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.
Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.
How complete is this profile?
Downloadable company intelligence charts
Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.
Therapeutic Portfolio Mix
Shows where the company portfolio is concentrated across broad therapeutic areas.
Portfolio distribution, not sales or market-share data.
Dosage Form Portfolio
Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.
Counts are product presentations, not production or sales volumes.
Equivalent Price Position
Shows whether safely comparable products are below, near or above the peer median unit price.
This is price-position intelligence, not sales, demand or market-share data.
Closest Portfolio Competitors
Highlights other manufacturers with the greatest generic overlap with this company portfolio.
Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.
Therapeutic areas
High-level clinical areas represented by this company’s current MedInfoBase portfolio.
Drug classes
More specific classes derived from the canonical generic and preserved curated classifications.
Dosage forms
How MedInfoBase classifies the portfolio
MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.
Deepest brand families
Unit-price positioning vs equivalent products
See where Mediflow Pharmaceutical (Pvt) Ltd. is priced against the market
10 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.
How MedInfoBase calculates price position
Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.
Portfolio overlap
Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.
🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock
Observed database signals
These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.
Medicine portfolio
This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.
| Brand | Generic | Strength | Form | Pack | Registration | Source-listed price | Unit price | Price position |
|---|---|---|---|---|---|---|---|---|
| Flow Dex | Water for Injection | 5 % | IV infusion | 100 mL | 083912 | PKR 87.52 | PKR 0.88/mL | No comparator |
| Flow Dex | Dextrose Anhydrous | 5 % | IV infusion | 500 mL | 084686 | PKR 133.02 | PKR 0.27/mL | 🔒 Pharma Pro |
| Flow Dex 10% | Dextrose Anhydrous | 10 % | IV infusion | 500 mL | 079601 | PKR 143.52 | PKR 0.29/mL | 🔒 Pharma Pro |
| Flow Dex 10% | Dextrose | 10% | IV infusion | 1000 mL | 084688 | PKR 201.27 | PKR 0.20/mL | 🔒 Pharma Pro |
| Flow Dex-5% | Dextrose | 5% | IV infusion | 1000 mL | 080618 | PKR 161.02 | PKR 0.16/mL | 🔒 Pharma Pro |
| Flow DS | Dextrose + Sodium chloride | NaCl 0.18g + Dextrose 4.30g/100 mL | IV infusion | 500 mL | 079597 | PKR 113.53 | PKR 0.23/mL | No comparator |
| Flow DS | Dextrose + Sodium chloride | NaCl 0.9g + Dextrose 5.0g/100 mL | IV infusion | 500 mL | 079600 | PKR 141.77 | PKR 0.28/mL | 🔒 Pharma Pro |
| Flow DS | Dextrose + Sodium chloride | NaCl 0.45g + Dextrose 5.0g/100 mL | IV infusion | 500 mL | 079602 | PKR 133.02 | PKR 0.27/mL | 🔒 Pharma Pro |
| Flow DS | Dextrose + Sodium chloride | 5% + 0.9% | IV infusion | 1000 mL | 084689 | PKR 169.77 | PKR 0.17/mL | 🔒 Pharma Pro |
| Flow Lactate DSource observed | Ringer's lactate electrolytes + Dextrose | 0.6 g | IV infusion | 1000 mL | 089080Official source ↗ | No indexed price | — | — |
| Flow Lactate D IV Infusion Each 100ml Contains:Sodium Chloride ……...…………..0.6gmSodium Lactate ……... ………….0.31gmCalcium Chloride 2H2O …….0.02gmPotassium Chloride …………..0.03gmDextrose Monohydrate ……....5.0gmWater for Injection qs to……..100mlSource observed | — | — | — | 1000 mL | 089080Official source ↗ | No indexed price | — | — |
| Flow NS | Sodium chloride | 0.90 g | IV infusion | 1000 mL | 080617 | PKR 154.02 | PKR 0.15/mL | No comparator |
| Flow NS | Sodium chloride | 0.9% w/v | IV infusion | 500 mL | 084684 | PKR 122.52 | PKR 0.25/mL | 🔒 Pharma Pro |
| Flow NS | Sodium chloride | 0.90 g | IV infusion | 100 mL | 084685 | PKR 87.52 | PKR 0.88/mL | No comparator |
| Flow RL | Sodium chloride | 0.6 g | IV infusion | 1000 mL | 080619 | PKR 169.77 | PKR 0.17/mL | No comparator |
| Flow RL | Ringer's lactate solution | NaCl 0.6g + KCl 0.04g + CaCl2 0.027g + Na lactate 0.32g/100 mL | IV infusion | 500 mL | 084687 | PKR 136.51 | PKR 0.27/mL | 🔒 Pharma Pro |
| Flow-MTZ | Metronidazole | 0.50 g | IV infusion | 100 mL | 085007 | PKR 120.02 | PKR 1.20/mL | No comparator |
| Flowtol | Mannitol | 20 % | IV infusion | 500 mL | 085006 | PKR 252.04 | PKR 0.50/mL | 🔒 Pharma Pro |
All 8 Mediflow Pharmaceutical brands in Pakistan
- Flow Dex Water for Injection, Dextrose Anhydrous · 5 % infusion
- Flow Dex 10% Dextrose Anhydrous, Dextrose · 10 % infusion, 10% infusion
- Flow Dex-5% Dextrose · 5% infusion
- Flow DS Dextrose + Sodium chloride · 5% + 0.9% infusion, NaCl 0.18g + Dextrose 4.30g/100 mL infusion, NaCl 0.45g + Dextrose 5.0g/100 mL infusion
- Flow NS Sodium chloride · 0.9% w/v infusion, 0.90 g infusion
- Flow RL Sodium chloride, Ringer's lactate solution · 0.6 g infusion, NaCl 0.6g + KCl 0.04g + CaCl2 0.027g + Na lactate 0.32g/100 mL infusion
- Flow-MTZ Metronidazole · 0.50 g infusion
- Flowtol Mannitol · 20 % infusion
Mediflow Pharmaceutical: common questions
How many products does Mediflow Pharmaceutical have in Pakistan?
Mediflow Pharmaceutical (Pvt) Ltd has 16 registered medicine presentations in Pakistan, sold under 8 brands and covering 8 generic medicines.
What are the main brands of Mediflow Pharmaceutical?
By number of registered strengths and packs, its largest brands are Flow DS (Dextrose + Sodium chloride), Flow NS (Sodium chloride), Flow Dex (Water for Injection, Dextrose Anhydrous), Flow Dex 10% (Dextrose Anhydrous, Dextrose) and Flow RL (Sodium chloride, Ringer's lactate solution). This is not a sales ranking.
Which therapy areas does Mediflow Pharmaceutical cover?
The most products are in Fluids & supportive care (15) and Anti-infectives (1).
Where can I see Mediflow Pharmaceutical medicine prices?
Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.
MedInfoBase company-intelligence methodology
This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.
Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.
Cite this record
Manufacturer recordRecords change over time. Please cite the access date so readers can locate the version you used.